Ad claims found unsubstantiated

AFT Pharmaceuticals has again suffered disappointment in the Federal Court over advertising for Maxigesic, which was found to be misleading AFT Pharmaceuticals contended that its claims that Maxigesic had superior efficacy to other paracetamol-ibuprofen combinations, but Reckitt Benckiser, manufacturer of competitor Nuromol, had begun legal action over these advertising claims. AFT was seeking to re-open